Related Experiment Video
Updated: Feb 22, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.7K
Temporary Mechanical Circulatory Support for Cardiogenic Shock
1University of Kentucky Gill Heart Institute, First Floor, Room G100, 1000 S. Limestone, Lexington, KY, 40536, USA.
Current Treatment Options in Cardiovascular Medicine
|September 16, 2017
Summary
Mechanical circulatory support (MCS) devices are increasingly used for cardiogenic shock due to limited benefits from traditional inotropes. This review covers key MCS devices, their clinical use, and comparative hemodynamic effects.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock signifies severe heart failure with substantial mortality.
- Current inotropes like dobutamine and milrinone offer limited survival benefits.
- Mechanical circulatory support (MCS) use has risen significantly for cardiogenic shock management.
Purpose of the Study:
- To review the physiologic principles, clinical evidence, and applications of common MCS devices.
- To outline indications, potential complications, and comparative data for major MCS technologies.
- To compare MCS devices based on implantation complexity and hemodynamic impact.
Main Methods:
- Literature review of current evidence on MCS for cardiogenic shock.
- Discussion of four primary MCS devices: intra-aortic balloon pump, Impella, TandemHeart, and ECMO.
- Comparative analysis of device implantation and hemodynamic effects.
Main Results:
- MCS devices offer alternatives to inotropes in severe heart failure.
- Each device presents unique profiles regarding implantation, hemodynamic support, and complications.
- A comparative understanding aids in selecting appropriate MCS for cardiogenic shock.
Conclusions:
- Mechanical circulatory support is a critical therapeutic option for cardiogenic shock.
- Understanding the nuances of different MCS devices is essential for optimal patient outcomes.
- Further research and comparative studies are needed to refine MCS utilization.
Related Concept Videos
01:24Blood Pressure Imbalances and Circulatory Shock
1.7K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.7K
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
983
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
983
01:30Cardiomyopathy II: Dilated Cardiomyopathy
634
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
634
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
391
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
391